WebWhen Andrew Witty headed up GlaxoSmithKline, he repeatedly told investors he was prepping the company for a future rife with payer pressure and cost-saving maneuvers that would hit pharma where it WebFeb 4, 2024 · UnitedHealth Group is promoting former GlaxoSmithKline leader Sir Andrew Witty, pictured here in 2010, to become the health insurance provider's next CEO …
UnitedHealth names former Glaxo CEO Witty to …
WebJul 2, 2012 · GlaxoSmithKline CEO Sir Andrew Witty expressed regret and said they have learned "from the mistakes that were made." "Today brings to resolution difficult, long-standing matters for GSK,"... WebApr 15, 2024 · Sir Andrew Witty, the former head of GlaxoSmithKline, current president of UnitedHealth Group and chief executive officer of Optum, is temporarily stepping away … china visa for malaysian in singapore
WHO tasks ex-GSK CEO Witty with hastening COVID-19 vaccine …
WebApr 12, 2024 · Andrew Witty Net Worth Andrew Witty has an estimated net worth of $50 million. He is a British business executive and the current CEO of UnitedHealth Group. Between 2008 and 2024, he was also the WebMar 24, 2016 · Glaxo SmithKline recently announced that its CEO, Andrew Witty, will be out the door as of March 31, 2024 – a development many were expecting. GSK has made headlines during Witty’s tenure,... Sir Andrew Philip Witty (born 22 August 1964) is a British business executive, who is the current chief executive officer (CEO) of UnitedHealth Group. He was also the CEO of GlaxoSmithKline between 2008 and 2024. He formerly held the role of chancellor of the University of Nottingham. See more Witty attended Malbank School (originally the "Nantwich and Acton Grammar School") in Nantwich, and then gained a bachelor's degree in economics from the University of Nottingham. See more Witty joined Glaxo UK in 1985 as a management trainee. He held various positions in the UK, including director of pharmacy & distribution in Glaxo Pharmaceuticals UK. He served as a vice president and general manager of … See more Witty was knighted in the 2012 New Year Honours for services to the economy and the UK pharmaceutical industry. He was also conferred the Honorary Citizen of Singapore in … See more Corporate boards • G1 Therapeutics, non-executive director (since 2024) • Synthego, member of the advisory board (since 2024) See more china visa new york appointment